Discovery of a Small Side Cavity in Sphingosine Kinase 2 that Enhances Inhibitor Potency and Selectivity.
Discovery of a Small Side Cavity in Sphingosine Kinase 2 that Enhances Inhibitor Potency and Selectivity.
复制标题
DOI:
10.1021/acs.jmedchem.9b01508
复制
发表时间:
2020-02-13
影响因子:
7.3
通讯作者:
Santos WL
中科院分区:
文献类型:
--
作者:
Sibley CD;Morris EA;Kharel Y;Brown AM;Huang T;Bevan DR;Lynch KR;Santos WL
The sphingosine-1-phosphate (S1P) signaling pathway is an attractive drug target due to its involvement in immune cell chemotaxis and vascular integrity. The formation of S1P is catalyzed by sphingosine kinase 1 or 2 (SphK1 or SphK2) from sphingosine (Sph) and ATP. Inhibition of SphK1 and 2 to attenuate levels of S1P has been reported to be efficacious in animal models of diseases such as cancer, sickle cell disease and renal fibrosis. While inhibitors of both SphKs have been reported, improvements in potency and selectivity are still needed. Towards that end, we performed a structure-activity relationship profiling of 8 (SLM6031434) and discovered a heretofore unrecognized side cavity that increased inhibitor potency toward SphK2. Interrogating this region revealed that relatively small hydrophobic moieties are preferred with 10 being the most potent SphK2 selective inhibitor (Ki = 89 nM, 73-fold SphK2 selective) with validated in vivo activity.
登录
查看更多内容
影响因子:
64.5
作者:
Chipuk JE;McStay GP;Bharti A;Kuwana T;Clarke CJ;Siskind LJ;Obeid LM;Green DR
通讯作者:
Green DR
影响因子:
4.1
作者:
Schnute, Mark E.;McReynolds, Matthew D.;Nagiec, Marek M.
通讯作者:
Nagiec, Marek M.
DOI:
10.1124/jpet.115.225862
发表时间:
2015-10-01
影响因子:
3.5
作者:
Kharel, Yugesh;Morris, Emily A.;Lynch, Kevin R.
通讯作者:
Lynch, Kevin R.
影响因子:
2.7
作者:
Congdon, Molly D.;Childress, Elizabeth S.;Santos, Webster L.
通讯作者:
Santos, Webster L.
影响因子:
3.7
作者:
Kharel Y;Agah S;Huang T;Mendelson AJ;Eletu OT;Barkey-Bircann P;Gesualdi J;Smith JS;Santos WL;Lynch KR
通讯作者:
Lynch KR